XPAR
BN
Market cap45bUSD
Sep 17, Last price
61.38EUR
1D
0.76%
1Q
-5.66%
Jan 2017
1.96%
Name
Danone SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Danone S.A., established in Paris, France, in 1899, is a major global player in the food and beverage sector. Its extensive operations cover Europe, North America, Latin America, the Asia Pacific region, Africa, and the Middle East. The company's business is organized into three principal divisions: Essential Dairy & Plant-Based, Specialized Nutrition, and Waters. Within its Essential Dairy & Plant-Based segment, Danone manufactures and distributes a broad range of items, including yogurts, various milk products, coffee creamers, beverages, plant-based alternatives, ice creams, desserts, and powdered nutritional proteins. These are sold under popular proprietary brands like Actimel, Activia, Alpro, Aptamil, Danette, Danio, Danonino, evian, Nutricia, Nutrilon, and Volvic, as well as licensed brands such as International Delight, Dunkin' Donuts, and Bailey's. The Specialized Nutrition division addresses diverse needs. It offers nutritional products designed for pregnant women, breastfeeding mothers, infants, and young children, marketed under brands including Aptamil, Nutrilon, Gallia, Cow & Gate, Blédina, Bebelac, Olvarit, and Happy Family Organics. This segment also encompasses medical nutrition solutions, providing tube feeding options (Nutrison), oral nutritional supplements (Fortimel and NutriDrink), and hypoallergenic formulas for children with allergies (notably Aptamil ProSyneo, Aptamil Pepti Syneo, and Neocate Syneo). Danone's Waters segment features a comprehensive portfolio of bottled waters, including those enhanced with natural fruit extracts, fruit juices, and vitamins. Key brands in this category include evian, Volvic, Aqua, Mizone, Bonafont, Villavicencio, Villa del Sur, Hayat, Sirma, Fontvella, Lanjarón, Salus, Aqua d'Or, and Zywiec Zdroj. The company employs a multi-channel distribution strategy, reaching consumers through major retail chains, traditional market outlets, convenience stores, and its growing e-commerce presence. Specialized products are also distributed through healthcare channels like hospitals, clinics, and pharmacies. The organization officially adopted its current name, Danone S.A., in April 2009, having previously operated as Groupe Danone.
Related entities
Subsidiaries (37)
DANONE - PRODUCTIE SI DISTRIBUTIE DE PRODUSE ALIMENTARE SRL
DANONE A.S.
DANONE ASIA PTE LTD
DANONE BELUX
DANONE CORPORATE FINANCE SERVICES
DANONE DEUTSCHLAND GMBH
DANONE FINANCE INTERNATIONAL
DANONE GLOBAL RESEARCH & INNOVATION CENTER
DANONE NUTRICIA AFRICA & OVERSEAS
DANONE NUTRICIA NEDERLAND B.V.
DANONE NUTRICIA SPA
DANONE NUTRICIA SPA SOCIETA' BENEFIT
DANONE PENSION MANAGEMENT GMBH
DANONE PRODUITS FRAIS FRANCE
DANONE RE
DANONE S.R.O.
DANONE SA
DANONE SCHWEIZ AG
DANONE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
FAN MILK INTERNATIONAL A/S
Key people
Henri Bruxelles
Executive Vice President - Waters and Africa, Member of the Executive Committee · since 2017
Veronique Penchienati-Bosetta
Executive Vice President Growth & Innovation, Member of the Executive Committee · since 2018
Gregg L. Engles
Director · since 2017
Director · since 2018
Isabelle Seillier
Director · since 2011
Independent Director · since 2017
Independent Director · since 2014
Headquarters & legal address
59 RUE LA FAYETTE
PARIS 75009
FR
PARIS 75009
FR
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||